TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Fatigue Severity Scale (FSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of Diabetic Retinopathy (DR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutralizing antibodies production against HPV 16/18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reporting rates of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Participation rates in CRC screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Period length of temperature rhythms closer to 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-rated competence scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes toward SGM people
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance with first round follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance at 12-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of CIN2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Long-term prognosis prediction
Endpoint domain: Mortality/survival
Primary endpoint: 30-day point prevalence abstinence at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery of home-visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall Survival (OS) prediction
Endpoint domain: Mortality/survival
Primary endpoint: Tibial tunnel volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete or nearly complete resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ-UI-SF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal muscle voltage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolapse rate of pelvic floor organ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heavy drinking days (HDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in COPM scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Effect size of BRIEF subscales
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Annual volume changes of total plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Annual volume changes of dense calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mitochondrial respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Sustained Attention (VSA) accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Memory (VM) accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Memory (VM) reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of postspinal anesthesia hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: self-perceived anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CV diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ultrasound maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glutamate concentration in the striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in physiological symptoms of job stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper limb disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-cold stress pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRC risk markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Peak torque of dorsiflexion movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak torque of plantarflexion movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tender point count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: skin edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: skin induration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: subcutaneous fibrous banding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Median duration of lactational amenorrhea (LA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative dysphagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastroesophageal reflux disease-Health Related Quality of Life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GERD-Q score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Neonatal death at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Time to deterioration
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of PTA episodes
Endpoint domain: Mortality/survival
Primary endpoint: Tomographic and Biomechanical Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer days with headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Better global perceived effect
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recommendation of the method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intention to use as primary contraceptive
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Suture penetrations into the vagina
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients achieving PASI 90 at week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving PASI 90 at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total body weight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving HbA1c <7.0% without hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee joint compressive forces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prophylaxis for frequent recurrent bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Management options for heavy menstrual bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Strategies to reduce bleeding during minor surgery or invasive procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Projected mean life expectancy
Endpoint domain: Mortality/survival
Primary endpoint: Percent flow (distal/proximal) after cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SpO2 saturation in distal calf of the cannulated leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of ovarian/tubal/peritoneal cancer registration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity of ovarian/tubal/peritoneal cancer registration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity for cause of death registration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: physiological quality-of-life scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Heart rate fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean arterial pressure fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fatigue improvement (MFIS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Quality of life improvement (MSQoL‐54)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increase in IL‐4 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality-of-life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intra-operator reproducibility of IFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-operator reproducibility of MNM angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-operator reproducibility of FMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-operator reproducibility of PL distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in the labor and delivery department
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Frequency of intrapartum and postpartum resource utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of experiencing a primary event
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of OTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of miR-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epithelial thickness distortion (EZI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder-7 scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ischemic index summed difference score (SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2nd Progression-Free Survival (PFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Low density lipoprotein cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Triglycerides reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Time to full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage negative opioid screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to test negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost-effectiveness of radiofrequency denervation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: weekly angina count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: short‐acting nitroglycerin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: severity of angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Injection Site Reactions (ISRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Injection Site Erythema (ISE)
Endpoint domain: Adverse events/effects
Primary endpoint: reduced violence against children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in ODI points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss per cm2 of transected surface of liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of clinically significant estimated blood loss (>800 mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: LDLc levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HDLc levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of any adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of carinal injuries
Endpoint domain: Adverse events/effects
Primary endpoint: quality-adjusted life-year gained
Endpoint domain: Mortality/survival
Primary endpoint: UACR (Urinary Albumin-to-Creatinine Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Positive screening for mental health disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: initial angular error correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermediate vision visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of major risk factors (systolic BP, diastolic BP, HbA1c, LDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Study participation acceptance rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reversal of frailty status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude of accommodation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial NITM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-fatal MI
Endpoint domain: Mortality/survival
Primary endpoint: need for repeat revascularization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: maximum grade of ARD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time of initial RID occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: repigmentation appearance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: maladaptive parenting beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: POSAS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sensitivity of immune cells to glucocorticoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Any-grade immune-mediated pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3/4 immune-mediated pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Fatal immune-mediated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Increased use of HFRT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: net cost of walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spatiotemporal outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sagittal-plane lower-limb kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in average length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean time to recover to maximum vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of pain days per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain quality ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity of NF‐κB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: COVID-19 mortality
Endpoint domain: Mortality/survival
Primary endpoint: percentage time in target 70‐180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean absolute glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cancer-specific survival (CSS)
Endpoint domain: Mortality/survival
Primary endpoint: ORM (Omentin-1 levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hsCRP (high-sensitivity C-reactive protein levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pupil contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment effect of omecamtiv mecarbil
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of restlessness
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of informational and motivational videos to encourage CRC screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of risky drinkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDA rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VD24 rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to 12-month remission
Endpoint domain: Mortality/survival
Primary endpoint: RRG3 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial length growth variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social participation intention
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Social participation behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: State anxiety levels in children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vitiligo Area Scoring Index (VASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: development of physical capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pump function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AFC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Normal respiratory diaphragm activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nonaccidental outpatient consultations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: crowding alleviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal Bone Change (MBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced having any recent sex
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: increased multiple partnerships
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: increased school enrolment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Upper esophageal (UES) pressure of primary peristalsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of secondary peristalsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of CABSI
Endpoint domain: Adverse events/effects
Primary endpoint: Dysfunctional beliefs sleep expectations subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Overall time in bed awake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Out-of-bedtime day-to-day variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of miR‐18a
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of PD‐L1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal microecology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge and attitudes regarding sexual and reproductive health (SRH) and contraception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Practices related to family planning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of participants gaining ≥2% of EOI weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants losing ≥2% of EOI weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V̇O2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CRPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of craniofacial injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of concussions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of fractures and lacerations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes